| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83881 |
5-羧基荧光素标记A20FMDV2-Gd-DOTA |
159 |
h |
2024-12-18 |
| 83882 |
竹节参皂苷Ⅳa脑靶向脂质体,C-Ⅳa-LPs,载药脂质体定制服务 |
160 |
axc |
2024-12-18 |
| 83883 |
cas:2249935-92-8，Mal-PEG1-Val-Cit-PAB-PNP，马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-PNP 酯 |
146 |
kx |
2024-12-18 |
| 83884 |
VG-PEG24-Chol 24单位PEG接头偶联胆固醇多肽 |
190 |
zyl |
2024-12-18 |
| 83885 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭环辛烯衍生物二苄基环辛烯 |
132 |
h |
2024-12-18 |
| 83886 |
CAS: 330970-70-2 Alloc-Val-Ala-OH，N-Alloc-L-valyl-L-alanine 或 (S)-2-((S)-2-(Allyloxycarbonylamino)-3-methylbutanamido)propanoic acid |
108 |
WYQ |
2024-12-18 |
| 83887 |
3-[(2-氨基乙基)二硫]丙酸，Aminoethyl-SS-propionic acid，ADC定制 |
150 |
wyh |
2024-12-18 |
| 83888 |
负载槲皮素与多柔比星的脂质体,QUE-DOX--Lips,靶向脂质体定制服务 |
204 |
axc |
2024-12-18 |
| 83889 |
DOTA-siRNA 螯合剂DOTA偶联siRNA纳米颗粒 |
163 |
h |
2024-12-18 |
| 83890 |
cFLFLFK-PEG12-Cy3的介绍 |
150 |
zyl |
2024-12-18 |
| 83891 |
DOTA-E{PEG4-E[Gly3-c(RGDfK)]2}2 |
144 |
h |
2024-12-18 |
| 83892 |
RGD修饰的共载姜黄素和阿霉素脂质体,cRGD-(C+D/LP)，提供荧光脂质体定制服务 |
187 |
axc |
2024-12-18 |
| 83893 |
螯合剂DOTA-NHS |
130 |
h |
2024-12-18 |
| 83894 |
Mal-PEG2-Val-Ala-PAB-PNP，马来酰亚胺-二聚乙二醇-VAL-ALA-PAB-PNP 酯 |
140 |
kx |
2024-12-18 |
| 83895 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)螯合物偶联配体[SHALs]) |
191 |
h |
2024-12-18 |
| 83896 |
DOTA(Gd))-b-PCL DOTA(Gd)螯合物修饰聚己内酯聚合物胶束 |
124 |
h |
2024-12-18 |
| 83897 |
土贝母苷甲脂质体，Tub,I-LPs，载药脂质体定制服务 |
114 |
axc |
2024-12-18 |
| 83898 |
半乳糖-RGD2 Galacto-RGD2 |
146 |
h |
2024-12-18 |
| 83899 |
DOTA-dPEG2-R954 DOTA偶联B1R拮抗剂R954 |
115 |
h |
2024-12-18 |
| 83900 |
竹节参皂苷Ⅳa脑靶向脂质体，脂质体纳米载体定制服务 |
162 |
axc |
2024-12-18 |
| 83901 |
cas:253863-34-2，Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP，ADC定制 |
111 |
wyh |
2024-12-18 |
| 83902 |
CAS: 1343407-91-9 Alloc-Val-Ala-PAB（或Val-Ala-PAB-OH） |
125 |
WYQ |
2024-12-18 |
| 83903 |
DOTA-PEG-NH2 DOTA-聚乙二醇-氨基 |
145 |
h |
2024-12-18 |
| 83904 |
R-8PEG-4PCL的介绍 |
134 |
zyl |
2024-12-18 |
| 83905 |
N3-tri-EG-OPFP，ADC定制 |
109 |
wyh |
2024-12-18 |
| 83906 |
cas:1949793-41-2， Mal-amido-PEG4-Val-Cit-PAB-OH，马来酰亚胺-四聚乙二醇-VAL-CIT-PAB |
121 |
kx |
2024-12-18 |
| 83907 |
甘露糖修饰脂质体包装ASFV,CP204L基因,多功能载药脂质体定制服务 |
133 |
axc |
2024-12-18 |
| 83908 |
DOTA-βA-NH2 |
121 |
h |
2024-12-18 |
| 83909 |
Py-ds-dmBut-OPFP，2101206-44-2，ADC定制 |
127 |
wyh |
2024-12-18 |
| 83910 |
ALD-di-EG-OPFP，ADC定制 |
120 |
wyh |
2024-12-18 |
| 83911 |
cas:2055047-18-0，Azido-PEG3-Val-Cit-PAB-PNP，叠氮-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
93 |
kx |
2024-12-18 |
| 83912 |
柠檬草精油脂质体,LONL,载药脂质体定制服务 |
163 |
axc |
2024-12-18 |
| 83913 |
cas:159857-79-1，Val-cit-PAB-OH，ADC定制 |
130 |
wyh |
2024-12-18 |
| 83914 |
双载IR780与HCQ的温敏脂质体（IR780/HCQ-Lip） |
157 |
axc |
2024-12-18 |
| 83915 |
endo BCN-PEG3-Val-Cit，(1R,8S,9S)-双环[6.1.0]壬-三聚乙二醇-VAL-CIT |
106 |
kx |
2024-12-18 |
| 83916 |
DOTA-(PEG28)2-A20FMDV2 双末端聚乙二醇化的A20FMDV2偶联DOTA大环配体 |
128 |
h |
2024-12-18 |
| 83917 |
PEG2K-Hyd-PEI聚合物包裹共载SS31肽和胰岛素的脂质体纳米粒,PHP-DPS@INS,NPs |
171 |
axc |
2024-12-18 |
| 83918 |
cas:2226472-28-0 ，DBCO-PEG4-Val-Cit-PAB-PNP，二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
107 |
kx |
2024-12-18 |
| 83919 |
FA-PEG-DOTA 叶酸-聚乙二醇-DOTA |
96 |
h |
2024-12-18 |
| 83920 |
OA-PEG5烷基链定制 |
147 |
zyl |
2024-12-18 |
| 83921 |
共载SS31肽和胰岛素的脂质体纳米粒,DPS@INS,NPs,脂质体纳米载体定制服务 |
149 |
axc |
2024-12-18 |
| 83922 |
DOTA-PEG27-Cys-VS |
114 |
h |
2024-12-18 |
| 83923 |
cas:1613321-01-9 ，6-Azidohexanoyl-Val-Cit-PAB，6-叠氮己酰-VAL-CIT-PAB |
104 |
kx |
2024-12-18 |
| 83924 |
MPA-PEG4-GB-6的功能与应用 |
173 |
zyl |
2024-12-18 |
| 83925 |
DOTA-PEG-GA DOTA-聚乙二醇-甘草次酸 |
101 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询